Gyre Therapeutics Enters Material Definitive Agreement
Ticker: GYRE · Form: 8-K · Filed: May 23, 2025 · CIK: 1124105
| Field | Detail |
|---|---|
| Company | Gyre Therapeutics, Inc. (GYRE) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-actions
TL;DR
Gyre Therapeutics just signed a big deal, filing an 8-K for a material definitive agreement.
AI Summary
On May 22, 2025, Gyre Therapeutics, Inc. entered into a material definitive agreement. The company, formerly known as Catalyst Biosciences, Inc. and Targacept Inc., is incorporated in Delaware and headquartered in San Diego, CA.
Why It Matters
This filing indicates a significant new contract or partnership for Gyre Therapeutics, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks and obligations, but their specific impact depends on the terms not detailed in this initial filing.
Key Players & Entities
- Gyre Therapeutics, Inc. (company) — Registrant
- May 22, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Diego, CA (location) — Principal executive offices
- Catalyst Biosciences, Inc. (company) — Former company name
- Targacept Inc (company) — Former company name
FAQ
What is the nature of the material definitive agreement entered into by Gyre Therapeutics?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on May 22, 2025.
When was the material definitive agreement entered into?
The earliest event reported, the entry into the material definitive agreement, occurred on May 22, 2025.
What is Gyre Therapeutics' principal executive office address?
Gyre Therapeutics' principal executive offices are located at 12770 High Bluff Drive, Suite 150, San Diego, CA 92130.
What were Gyre Therapeutics' former company names?
Gyre Therapeutics was formerly known as Catalyst Biosciences, Inc. and Targacept Inc.
In which state is Gyre Therapeutics incorporated?
Gyre Therapeutics, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding GYRE THERAPEUTICS, INC. (GYRE).